Soligenix Insider Trades
NASDAQ: SNGXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 0 · $0
- Shares bought / sold
- 0 / 0
- Net activity
- Net buying $0
Soligenix insider activity
No Soligenix insider transactions were reported in the last 12 months; the table shows the most recent historical filings. The most recent filing shows SCHABER CHRISTOPHER J (CHAIRMAN, CEO AND PRESIDENT) buying 15,132 shares at $1.32 on Oct 2, 2025. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put SNGX's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
SNGX insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 2, 2025 | SCHABER CHRISTOPHER JCHAIRMAN, CEO AND PRESIDENT | Buy | 15,132 | $20.00K | Form 4 |
| May 18, 2022 | SCHABER CHRISTOPHER JCHAIRMAN, CEO AND PRESIDENT | Buy | 20,000 | $8.87K | Form 4 |
| May 18, 2022 | Straube RichardSENIOR VICE PRESIDENT AND CMO | Buy | 8,000 | $4.00K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4